AKR1B10: A new diagnostic marker of non-small cell lung carcinoma in smokers

Clinical Cancer Research

Volumn 11, Issue 5, 2005, Pages 1687-1690

  Penning, Trevor M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOKETOREDUCTASE 1B10; ANTINEOPLASTIC AGENT; BETA CAROTENE; BIOLOGICAL MARKER; CISPLATIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXIDOREDUCTASE; RETINOID; TOLRESTAT; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DRUG METABOLISM; HUMAN; LUNG NON SMALL CELL CANCER; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOKING; UPREGULATION;

ALCOHOL OXIDOREDUCTASES; ALDEHYDE REDUCTASE; CARCINOMA, NON-SMALL-CELL LUNG; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; PROGNOSIS; SIGNAL TRANSDUCTION; SMOKING; TRETINOIN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 16444364105     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-0071     Document Type: Note

References (23)

1. Penning TM. Introduction and overview of the aldo-keto reductase superfamily. In: Penning TM, Petrash JM, editors. Aldo-keto reductases and toxicant metabolism. Washington (DC): American Chemical Society; 2004. p. 3-21.
2. Hyndman DJ, Bauman DR, Heredia VV, Penning TM. The aldo-keto reductase superfamily homepage. Chem Biol Interact 2003;143-4:621-31.
3. Vander Jagt DL, Hassbrook RK, Hunsaker LA, Brown WM, Royer RE. Metabolism of the 2-oxoaldehyde methylglyoxal by aldose reductase and by glyoxalase-I: roles for glutathione in both enzymes and implications for diabetic complications. Chem Biol Interact 2001;130-2:549-62.
4. Crosas B, Hyndman D, Gallego O, Martras S, Pares X, Flynn TG. Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem J 2003;373:973-9.
5. Hyndman DJ, Flynn TG. Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family. Biochim Biophys Acta 1998;1399:198-202.
6. Cho DC, Fan ST, Chung SSM. Identification and characterization of a novel human aldose reductase like gene. J Biol Chem 1988;273:11429-35.
7. Hsu N-Y, Ho H-C, Chow K-C, et al. Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res 2001;61:2727-31.
8. Deng HB, Parekh HK, Chow K-C, Simpkins H. Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells. J Biol Chem 2002;277:15035-43.
9. Burczynski ME, Lin H-K, Penning TM. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAH), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenases. Cancer Res 1999;59:607-14.
10. Ciaccio PJ, Tew KD. cDNA and deduced amino acid sequences of a human colon dihydrodiol dehydrogenase. Biochim Biophys Acta 1994;1186:129-32.
11. Ciaccio PJ, Jaiswal AK, Tew KD. Regulation of human dihydrodiol dehydrogenase by Michael acceptor xenobiotics. J Biol Chem 1994;269:15558-62.
12. Palackal NT, Lee SH, Harvey RG, Blair IA, Penning TM. Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells. J Biol Chem 2002;24799-808.
13. Rosette C, Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274;1996:1194-7.
14. Nadkarni VGK, Bohren KM, Sheikh-Hamad D. Osmotic response element enhancer activity. Regulation through p38 kinase and mitogen-activated extracellular signal-regulated kinase kinase. J Biol Chem 1999;274:20185-90.
15. Itoh KCT, Takahashi S, Ishii T, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997;235:313-22.
16. Maser E, Breyer-Pfaff U. Competing roles of reductases in the detoxification of the tobacco-specific nitrosamine ketone NNK. In: Penning TM, Petrash JM, editors. Aldo-keto reductases and toxicant metabolism. Washington (DC): American Chemical Society; 2004. p. 67-82.
17. Penning TM, Burczynski ME, Hung C-F, McCoull KD, Palackal NT, Tsuruda LS. Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox-active o-quinones. Chem Res Toxicol 1999;12:1-18.
18. Penning TM, Burczynski ME, Jez JM, Hung C-F, Lin H-K, Ma H. Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 2000;351:67-77.
19. Penning TM. Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action. Hum Reprod Update 2003;9:193-205.
20. Desmond JC, Mountford JC, Drayson MT, et al. The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. Cancer Res 2003;63:505-12.
21. Khuri FR, Lotan R. Retinoids in lung cancer: friend, foe or fellow traveler? J Clin Oncol 2004;22:3435-7.
22. von Lintig J, Vogt K. Filling the gap in vitamin A research. Molecular identification of an enzyme cleaving β-carotene to retinal. J Biol Chem 2000;275:11915-20.
23. Brabender J, Metzger R, Salonga D, et al. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis. Carcinogenesis. Epub ahead of print 2004 Dec 23.